Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Observer Blind Randomized, Multi-center, Controlled Study to Evaluate the Effect of Novartis Vaccine's Meningococcal B Recombinant and MenACWY Conjugate Vaccines on Pharyngeal Carriage of N. Meningitidis in Young Adults

NCT01214850 is registered in ClinicalTrials.gov with Novartis Vaccines as lead sponsor.

NCT NCT01214850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01214850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Observer Blind Randomized, Multi-center, Controlled Study to Evaluate the Effect of Novartis Vaccine's Meningococcal B Recombinant and MenACWY Conjugate Vaccines on Pharyngeal Carriage of N. Meningitidis in Young Adults
Lead sponsor
Novartis Vaccines
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2010
Completion date
January 31, 2012
Enrollment
2,968 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

n. meningitidis carriage